Scientists design leading therapeutic drug in fight against Ebola virus

Auburn scientists design promising drug candidate to fight the deadly Ebola virus

An Auburn University research team has produced a new drug candidate that could one day slow or even stop the deadly Ebola virus. The discovery will be published in an upcoming issue of the journal Bioorganic and Medicinal Chemistry.

The group, led by professor of chemistry and biochemistry Stewart Schneller, has designed a compound aimed at reversing the immune-blocking abilities of certain viruses, including Ebola.

"In simple terms, the Ebola virus has the ability to turn off the body's natural ," Schneller said. "We have made a small tweak in compound structure that will turn that response back on."

Currently there are no drugs to combat Ebola, and the death toll from recent outbreaks in West Africa is approaching 1,000, according to the World Health Organization. Immunizations might one day lessen the virus' impact, but vaccines have limitations that other drugs do not.

"Vaccines offer a promising therapeutic approach, but they can't be given to everyone in a population, including the young, the elderly and those with compromised immune systems," said Schneller. "This and other factors support the need for drug therapy as we fight this disease."

Ebola is a severe, often fatal illness in humans. Outbreaks have occurred primarily in remote villages in Central and West Africa near tropical rainforests. It is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.

Schneller has studied Ebola for the past decade. The drug design research taking place in his laboratory has focused on combatting a variety of virus-caused infections, including Smallpox, Yellow Fever, Hepatitis C and others.

More extensive studies with Schneller's new discovery are already underway through a partnership with the National Institutes of Health.

"It's a long process that has taken 10 years to get to this point," said Schneller. "You think you can outsmart the or outsmart nature, but that does not happen. So we have to redesign. We made this one small change and it has made a dramatic difference."

add to favorites email to friend print save as pdf

Related Stories

How does Ebola virus spread and can it be stopped?

Aug 06, 2014

As a deadly Ebola outbreak continues in West Africa, health officials are working to calm fears about how the virus spreads, while encouraging those with symptoms to get medical care. Typically, outbreaks ...

FDA lifts hold on experimental Ebola drug

Aug 07, 2014

Federal health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use against an unprecedented outbreak of the deadly virus in West Africa.

5 things to know about Ebola outbreak in W. Africa

Jul 28, 2014

(AP)—There has been panic and fear about the deadly Ebola disease spreading ever since Nigerian health officials reported Friday that a Liberian man sick with the disease had traveled to Togo and then Nigeria ...

World Bank pledges $200 million to fight Ebola

Aug 04, 2014

The World Bank said Monday that it would provide up to $200 million to Guinea, Liberia and Sierra Leone to help the West African nations contain a deadly Ebola outbreak.

Recommended for you

Sierra Leone: WHO too slow to help doc with Ebola

6 hours ago

Sierra Leone accused the World Health Organization on Monday of being "sluggish" in facilitating an evacuation of a doctor who died from Ebola before she could be sent out of the country for medical care.

Dutch doctors feared to have Ebola leave hospital

6 hours ago

Two Dutch doctors flown home from west Africa after fears they might have been contaminated with the killer Ebola virus have left hospital "in good health," their employer, the Lion Heart Medical Centre, said Monday.

Strategic self-sabotage? MRSA inhibits its own growth

11 hours ago

Scientists at the University of Western Ontario have uncovered a bacterial mystery. Against all logic, the most predominant strain of methicillin-resistant Staphylococcus aureus (MRSA) in North American produces an enzyme ...

US works to step up Ebola aid, but is it enough?

13 hours ago

The American strategy on Ebola is two-pronged: Step up desperately needed aid to West Africa and, in an unusual step, train U.S. doctors and nurses for volunteer duty in the outbreak zone. At home, the goal ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

EyeNStein
not rated yet Aug 09, 2014
The astounding clarity of an article which reduces the complexity of the human immune system to an on-off switch!
You can tell from the enlarged picture of '05-Y316' that it must be a wonder drug.